1 02 2020 8 25 • • • • 2 1. 2. 3. 4. • 3 4 1 Modalis Therapeutics CRISPR : 4883 2016 1 4 4 12 12 6 1 3 3 Modalis Therapeutics Corporation EdiGENE Inc. Modalis Therapeutics Inc. 2 CRISPR-GNDM Editas Medicine, Inc. CRISPR/Cas9 : 4883 J-Startup EdiGENE Inc. Modalis Therapeutics Inc. CRISPR-GNDM 2016 1 CEO 16-5 Y’s 4F 2016 2017 2017 2017 2018 2019 2019 Modalis Therapeutics Inc. (51 Moulton st. Cambridge MA) CRISPR 2,549,200 27,200,000 17 ( [ ]4 J-STARTUP 2020 7 31 [ ]13 2018 ) PhD 7 2019 2019 8 2019 2019 2020 2020 9 11 4 8 5 1 Modalis Therapeutics 6 next big t関連タグ:
日付 | 始値 | 高値 | 安値 | 終値 | 出来高 |
---|---|---|---|---|---|
2020-08-24 | 3405 | 3800 | 3330 | 3800 | 4631400 |
2020-08-21 | 3465 | 3480 | 3150 | 3295 | 3115500 |
2020-08-20 | 3535 | 3725 | 3280 | 3395 | 5878300 |
2020-08-19 | 3175 | 3540 | 3155 | 3400 | 6501400 |
2020-08-18 | 2768 | 3170 | 2733 | 3080 | 7583900 |
2020-08-17 | 2710 | 2765 | 2645 | 2668 | 2167300 |